Abstract
Fanconi-Bickel syndrome (FBS) is a rare autosomal-recessive inborn error of metabolism characterized by hepatorenal glycogen accumulation, Fanconi nephropathy and impaired utilization of glucose and galactose1. To date, no underlying enzymatic defect in carbohydrate metabolism has been identified. Therefore, and because of the impairment of both glucose and galactose metabolism, a primary defect of monosaccharide transport across membranes has been suggested1–4. Here we report mutations in the gene encoding the facilitative glucose transporter 2 (GLUT2) in three FBS families, including the original patient described in 1949 by Fanconi and Bickel5 Homozygous mutations were found in affected individuals, whereas all parents tested were heterozygous for the respective mutation. Because all detected mutations (δT446–449, C1251T and C1405T) predict truncated translation products that cannot be expected to have functional monosaccharide transport activity, GLUT2 mutations are probably the cause of FBS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Manz, F. et al. Fanconi-Bickel syndrome. Pediatr. Nephrol. 1, 509–518 (1987).
Odièvre, M. Glycogénose hépato-renale avec tubulopathie complexe. Rev. Inst. Hepatol. 16, 1–70 (1966).
Fellers, F.X., Piedrahita, V. & Galan, E.M. Pseudo-phlorizin diabetes. Pediatr. Res. 1, 304–306 (1967).
MÜller, D., Santer, R., Krawinkel, M., Christiansen, B. & Schaub, J. Fanconi-Bickel syndrome presenting in neonatal screening for galactosaemia. J. Inherited Metab. Dis. 20, 607–608 (1997).
Fanconi, G. & Bickel, H. Die chronische Aminoacidurie (Aminosaurediabetes oder nephrotisch-glukosurischer Zwergwuchs) bei der Glykogenose und der Cystinkrankheit. Helv. Paediatr. Acta 4, 359–396 (1949).
Mueckler, M. Facilitative glucose transporters. Eur. J. Biochem. 219, 713–725 (1994).
Fukumoto, H. et al. Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein. Proc. Natl. Acad. Sci. USA 85, 5434–548 (1988).
Permutt, M.A. et al. Cloning and functional expression of a human pancreatic islet glucose-transporter cDNA. Proc. Natl. Acad. Sci. USA 86, 8688–8692 (1989).
Takeda, J., Kayano, T., Fukomoto, H. & Bell, G.I. Organization of the human GLUT2 (pancreatic β-cell and hepatocyte) glucose transporter gene. Diabetes 42, 773–777 (1993).
Mueckler, M. et al. Sequence and structure of a human glucose transporter. Science 229, 941–945 (1985).
Maiden, M.C.J., Davis, E.O., Baldwin, S.A., Moore, D.C.M. & Henderson, P.J.F. Mammalian and bacterial sugar transport proteins are homologous. Nature 325, 641–643 (1987).
Holman, G.D. Side-specific photolabelling of the hexose transporter. Biochem. Soc. Trans. 17, 438–440 (1989).
Katagiri, H. et al. Substitution of leucine for tryptophan 412 does not abolish cytochalasin B labeling but markedly decreases the intrinsic activity of GLUT1 glucose transporter. J. Biol. Chem. 266, 7769–7773 (1991).
Garcia, J.C., Strube, M., Leingang, K., Keller, K. & Mueckler, M. Amino acid substitutions at tryptophan 388 and tryptophan 412 of the HepG2 (Glutl) glucose transporter inhibit transport activity and targeting to the plasma membrane in Xenopus oocytes. J. Biol. Chem. 267, 7770–7776 (1992).
Ishihara, H. et al. The glucose transport activity of GLUT1 is markedly decreased by substitution of a single amino acid with a different charge at residue 415. Biochem.Biophys. Res. Commun. 176, 922–930 (1991).
Oka, Y. et al. C-terminal truncated glucose transporter is locked into an inward-facing form without transport activity. Nature 345, 550–553 (1990).
Aperia, A., Bergqvist, G., Linné, T. & Zetterström, R., Fanconi syndrome with malabsorption and galactose intolerance, normal kinase and transferase activity. Acta Paediatr. Scand. 70, 527–533 (1981).
Mueckler, M. et al. A mutation in the Glut2 glucose transporter gene of a diabetic patient abolishes transport. J. Biol. Chem. 269, 17765–17767 (1994).
Shimada, F. et al. Identification of two novel amino acid polymorphisms in beta-cell/liver (GLUT2) glucose transporter in Japanese subjects. Diabetologia 38, 211–215 (1995).
Matsubara, A., Tanizawa, Y., Matsutani, A., Kaneko, T., Kaku, K. Sequence variations of the pancreatic islet/liver glucose transporter (GLUT2) gene in Japanese subjects with noninsulin dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 80, 3131–3135 (1995).
De Vivo, D.C. et al. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N. Engl. J. Med. 325, 703–709 (1991).
Chen, Y.T. & Burchell, A. Glycogen storage diseases, in The Metabolic and Molecular Basis of Inherited Disease, 7th ed. (eds Scriver, C.R. et al.) 935–965 (McGraw-Hill, New York, 1995).
Gitzelmann, R. Glukagonprobleme bei den Glykogenspeicherkrankheiten. Helv. Paediatr. Acta 12, 425–479 (1957).
Sambrook, J., Fritsch, E.F. & Maniatis, T., Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1989).
Lowe, T., Sharefkin, J., Yang, S.Q. & Dieffenbach, C.W. A computer program for selection of oligonucleotide primers for polymerase chain reactions. Nucleic Acids Res. 18, 1757–1761 (1990).
Saiki, R.K. et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487–491 (1988).
Budowle, B., Chakraborty, R., Giusti, A.M., Eisenberg, A.J. & Allen, R.C. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am. J. Hum. Genet. 48, 137–144 (1991).
Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K. & Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA 86, 2766–2770 (1989).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Santer, R., Schneppenheim, R., Dombrowski, A. et al. Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome. Nat Genet 17, 324–326 (1997). https://doi.org/10.1038/ng1197-324
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng1197-324
This article is cited by
-
Importance about use of high-throughput sequencing in pediatric: case report of a patient with Fanconi-Bickel syndrome
BMC Pediatrics (2024)
-
Clinical, genetic profile and therapy evaluation of 11 Chinese pediatric patients with Fanconi-Bickel syndrome
Orphanet Journal of Rare Diseases (2024)
-
Monogenic diabetes
Nature Reviews Disease Primers (2023)
-
Nutrient sensors and their crosstalk
Experimental & Molecular Medicine (2023)
-
Inherited Fanconi syndrome
World Journal of Pediatrics (2023)